QDEL US Equity
QuidelOrtho CorpHealth Care · In Vitro & In Vivo Diagnostic Substances · CIK 1906324 · FY ends Jan 1$14.74
-0.11 (-0.74%)
USD · as of 2026-08-21 · marketstack
Short interest· FINRA consolidated · settlement 2026-07-31
6 settlement cycles| Shares short | 13.0M |
| % of shares out | 19.0% |
| Days to cover | 12.7 |
| Δ vs 2026-07-15 | +10.2% |
bars = shares short · line = days to cover (own scale)
| Settlement | Shares short | Δ vs prior | Avg daily volume | Days to cover |
|---|
| 2026-07-31 | 13,005,131 | +10.2% | 1,022,227 | 12.7 |
| 2026-07-15 | 11,802,749 | +2.6% | 1,209,030 | 9.8 |
| 2026-06-30 | 11,505,504 | -6.9% | 2,152,143 | 5.3 |
| 2026-06-15 | 12,353,554 | +2.7% | 1,738,588 | 7.1 |
| 2026-05-29 | 12,029,248 | +2.0% | 1,763,805 | 6.8 |
| 2026-05-15 | 11,794,699 | -7.9% | 2,609,369 | 4.5 |
FINRA Rule 4560 · twice monthly, published ~a week later.
Output of a disclosed model — assumptions may be wrong. Research, not investment advice. See the Disclaimer.
